New class of HIV integrase inhibitors that block viral replication in cell culture

Current Biology

Volumn 12, Issue 14, 2002, Pages 1169-1177

  Pannecouque, Christophe ^a   Pluymers, Wim ^a   Van Maele, Bénédicte ^a   Tetz, Victor ^b   Cherepanov, Peter ^a   De Clercq, Erik ^a   Witvrouw, Myriam ^a   Debyser, Zeger ^a  

^a REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

^b PAVLOV FIRST SAINT PETERSBURG STATE MEDICAL UNIVERSITY   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

INTEGRASE INHIBITOR; PYRIMIDINE DERIVATIVE;

ARTICLE; CELL LINE; CHEMISTRY; DRUG EFFECT; GENE VECTOR; GENETICS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; MICROBIOLOGICAL EXAMINATION; PHYSIOLOGY; SIMIAN IMMUNODEFICIENCY VIRUS; STRUCTURE ACTIVITY RELATION; VIRUS REPLICATION;

CELL LINE; GENETIC VECTORS; HIV INTEGRASE INHIBITORS; HIV-1; HUMANS; MICROBIAL SENSITIVITY TESTS; PYRIMIDINES; SIMIAN IMMUNODEFICIENCY VIRUS; STRUCTURE-ACTIVITY RELATIONSHIP; VIRUS REPLICATION; HUMAN; SIV; SUPPORT, NON-U.S. GOV'T;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2;

EID: 0037162281     PISSN: 09609822     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-9822(02)00952-1     Document Type: Article

References (52)

1. New developments in anti-HIV chemotherapy
2. HIV chemotherapy
3. Requirement of active human immunodeficiency virus type 1 integrase enzyme for productive infection of human T-lymphoid cells
4. Integration is essential for efficient gene expression of human immunodeficiency virus type 1
5. HIV-1 integration as a target for antiretroviral therapy: A review
6. Integration
7. Human immunodeficiency virus type 1 preintegration complexes: Studies of organization and composition
8. Reversal of integration and DNA splicing mediated by integrase of HIV
9. Repair of gaps in retroviral DNA integration intermediates
10. Modeling the late steps in HIV-1 retroviral integrase-catalyzed DNA integration
11. A high-throughput, non-radioactive microtiter plate assay for activity of the HIV integrase protein
12. A novel assay for the DNA strand-transfer reaction of HIV-1 integrase
13. Differential inhibition of HIV-1 preintegration complexes and purified integrase protein by small molecules
14. Human immunodeficiency virus integration protein expressed in Escherichia coli possesses selective DNA cleavage activity
15. Activities of human immunodeficiency virus (HIV) integration protein in vitro: Specific cleavage and integration of HIV DNA
16. Retroviral integrase inhibitors year 2000: Update and perspectives
17. HIV-1 integrase inhibitors: Past, present, and future
18. Inhibition of HIV-1 integrase by small molecules: The potential for a new class of AIDS chemotherapeutics
19. T30177, an oligonucleotide stabilized by an intramolecular guanosine octet, is a potent inhibitor of laboratory strains and clinical isolates of human immunodeficiency virus type 1
20. Mode of interaction of G-quartets with the integrase of human immunodeficiency virus type 1 (HIV-1)
21. Human immunodeficiency virus glycoprotein gp120 as the primary target for the antiviral action of AR177 (zintevir)
22. Inhibitors of HIV-1 replication that inhibit HIV integrase
23. Resistance to the anti-HIV-1 compound L-chicoric acid results from a single mutation at amino acid 140 of integrase
24. Viral entry as the primary target for the anti-HIV activity of chicoric acid and its tetra-acetyl esters
25. Inhibition of HIV-1 integrase by flavones, caffeic acid phenethyl ester (CAPE) and related compounds
26. Effects of tyrphostins, protein kinase inhibitors, on human immunodeficiency virus type 1 integrase
27. (-)-Arctigenin as a lead structure for inhibitors of HIV-1 integrase
28. Hydroxylated aromatic inhibitors of HIV-1 integrase
29. Inhibition of HIV-1 integrase by curcumin
30. Antiretroviral agents as inhibitors of both human immunodeficiency virus type 1 integrase and protease
31. Potent inhibitors of HIV-1 integrase: Identification of a novel four-point pharmacophore and tetracyclines as novel inhibitors
32. Inhibitors of human immunodeficiency virus integrase
33. Inhibition of the in vitro integration of Moloney murine leukemia virus DNA by the DNA minor groove binder netropsin
34. Highly potent synthetic polyamides, bisdistamycins, and lexitropsins as inhibitors of human immunodeficiency virus type 1 integrase
35. Triplex-mediated inhibition of HIV DNA integration in vitro
36. Alternate strand DNA triple helix-mediated inhibition of HIV-1 U5 long terminal repeat integration in vitro
37. Peptide inhibitors of HIV-1 integrase dissociate the enzyme oligomers
38. Intracellular expression of single-chain variable fragments to inhibit early stages of the viral life cycle by targeting human immunodeficiency virus type 1 integrase
39. Structure-activity relationships and binding mode of styrylquinolines as potent inhibitors of HIV-1 integrase and replication of HIV-1 in cell culture
40. Thiazolothiazepine inhibitors of HIV-1 integrase
41. Inhibitors of strand transfer that prevent integration and inhibit HIV-1 replication in cells
42. Structure of the HIV-1 integrase catalytic domain complexed with an inhibitor: A platform for antiviral drug design
43. 4-Aryl-2, 4-dioxobutanoic acid inhibitors of HIV-1 integrase and viral replication in cells
44. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector
45. Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo
46. Human immunodeficiency virus type 1 integrase protein promotes reverse transcription through specific interactions with the nucleoprotein reverse transcription complex
47. Nucleosides. V. The monomesylates of 1-(2′-deoxy-β-D-lyxofuranosyl)thymidine
48. An antiviral target on reverse transcriptase of human immunodeficiency virus type 1 revealed by tetrahydroimidazo-(4,5,1-jk)(1,4) benzodiazepin-2 (1H)-one and -thione derivatives
49. A two plasmid co-expression system in Escherichia coli for the production of virion-like reverse transcriptase of the human immunodeficiency virus type 1
50. Assays for the evaluation of HIV-1 integrase inhibitors
51. A quantitative assay for HIV DNA integration in vivo